Thu 13 Jan 2022 DORC announces strategic partnership with WEFIS GmbH for research and development of innovative ophthalmic instruments based on an equity investment | Press Release Zuidland, NETHERLANDS – DORC International and WEFIS GmbH are excited to announce a strategic partnership, based on an equity investment by DORC....
Mon 30 Aug 2021 Leading a Global Leader, with Pierre Billardon | Podcast by Ophthalmology Innovation Summit (USA) "Dutch Ophthalmic Research Center (DORC) is a world-leading retinal surgical instrument developer....
Fri 9 Jul 2021 Interview with Pierre Billardon, DORC CEO | Ophthalmology Management, July 2021 In an interview with Ophthalmology Management magazine DORC CEO Pierre Billardon said he was satisfied with the 2020 results and expects...
Wed 16 Jun 2021 DORC launches EVA EquiPhaco™ angled needles | NEW DORC introduces EVA EquiPhaco™ angled needles....
Fri 21 May 2021 DORC launches new disposable phaco fragmentation needles | NEW DORC is pleased to introduce the new disposable phaco fragmentation needles in 20G and 23G to complement its existing range of reusable phaco...
Mon 29 Jun 2020 DORC launches new range of EVA EquiPhaco™ needles and sleeves | new DORC is excited to launch our new range of EVA EquiPhaco needles and sleeves. The EVA EquiPhaco™ range will deliver superior performance and ...
Wed 30 Nov 2022 DORC Cairo Retina Meeting Symposium | INVITATION Planning to attend Cairo Retina Meeting in January?...
Fri 3 Apr 2020 CEO statement on coronavirus | COVID-19 The COVID-19 pandemic is having an unprecedented impact on our world, and clearly our first thoughts are with those people affected by this virus. ...